P08908 5HT1A_HUMAN
Gene name: HTR1A
Protein name: 5-hydroxytryptamine receptor 1A
List of molecules and drugs that target protein P08908
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P08908_DB00216 | DB00216 | Eletriptan | agonist | PWVXXGRKLHYWKM-LJQANCHMSA-N | CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2 | |
2 | P08908_DB00246 | DB00246 | Ziprasidone | agonist | Ki(nM) = 1.6 | MVWVFYHBGMAFLY-UHFFFAOYSA-N | ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1 |
3 | P08908_DB00247 | DB00247 | Methysergide | agonist | KPJZHOPZRAFDTN-NQUBZZJWSA-N | [H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO | |
4 | P08908_DB00248 | DB00248 | Cabergoline | agonist | KORNTPPJEAJQIU-KJXAQDMKSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC | |
5 | P08908_DB00315 | DB00315 | Zolmitriptan | agonist | Ki(nM) = 79.0 Kd(nM) = 1.8 | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12 |
6 | P08908_DB00320 | DB00320 | Dihydroergotamine | agonist | LUZRJRNZXALNLM-JGRZULCMSA-N | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O | |
7 | P08908_DB00321 | DB00321 | Amitriptyline | inhibitor | Ki(nM) = 450.0 | KRMDCWKBEZIMAB-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
8 | P08908_DB00363 | DB00363 | Clozapine | antagonist | Ki(nM) = 6.4 IC50(nM) = 150.0 | QZUDBNBUXVUHMW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 |
9 | P08908_DB00408 | DB00408 | Loxapine | binder | Ki(nM) = 2456.0 | XJGVXQDUIWGIRW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2 |
10 | P08908_DB00413 | DB00413 | Pramipexole | agonist | Ki(nM) = 6514.0 | FASDKYOPVNHBLU-ZETCQYMHSA-N | CCCN[C@H]1CCC2=C(C1)SC(N)=N2 |
11 | P08908_DB00422 | DB00422 | Methylphenidate | n/a | DUGOZIWVEXMGBE-UHFFFAOYSA-N | COC(=O)C(C1CCCCN1)C1=CC=CC=C1 | |
12 | P08908_DB00458 | DB00458 | Imipramine | activator | Ki(nM) = 5800.0 | BCGWQEUPMDMJNV-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
13 | P08908_DB00477 | DB00477 | Chlorpromazine | antagonist | Ki(nM) = 116.4 | ZPEIMTDSQAKGNT-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2 |
14 | P08908_DB00490 | DB00490 | Buspirone | partial agonist | Ki(nM) = 3.1 IC50(nM) = 25.0 EC50(nM) = 15.0 | QWCRAEMEVRGPNT-UHFFFAOYSA-N | O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1 |
15 | P08908_DB00502 | DB00502 | Haloperidol | n/a | Ki(nM) = 1202.0 IC50(nM) = 1500.0 | LNEPOXFFQSENCJ-UHFFFAOYSA-N | OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1 |
16 | P08908_DB00540 | DB00540 | Nortriptyline | antagonist | Ki(nM) = 294.0 | PHVGLTMQBUFIQQ-UHFFFAOYSA-N | CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
17 | P08908_DB00543 | DB00543 | Amoxapine | antagonist | Ki(nM) = 221.0 | QWGDMFLQWFTERH-UHFFFAOYSA-N | ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1 |
18 | P08908_DB00571 | DB00571 | Propranolol | other/unknown | Ki(nM) = 31.0 IC50(nM) = 3981.0 | AQHHHDLHHXJYJD-UHFFFAOYSA-N | CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2 |
19 | P08908_DB00574 | DB00574 | Fenfluramine | agonist | DBGIVFWFUFKIQN-UHFFFAOYSA-N | CCNC(C)CC1=CC=CC(=C1)C(F)(F)F | |
20 | P08908_DB00589 | DB00589 | Lisuride | agonist | Ki(nM) = 0.4 Kd(nM) = 501.0 | BKRGVLQUQGGVSM-KBXCAEBGSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC |
21 | P08908_DB00656 | DB00656 | Trazodone | antagonist | Ki(nM) = 96.0 EC50(nM) = 785.0 | PHLBKPHSAVXXEF-UHFFFAOYSA-N | ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1 |
22 | P08908_DB00669 | DB00669 | Sumatriptan | agonist | Ki(nM) = 230.0 IC50(nM) = 398.0 Kd(nM) = 3162.0 EC50(nM) = 1000.0 | KQKPFRSPSRPDEB-UHFFFAOYSA-N | CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 |
23 | P08908_DB00696 | DB00696 | Ergotamine | agonist | XCGSFFUVFURLIX-VFGNJEKYSA-N | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O | |
24 | P08908_DB00714 | DB00714 | Apomorphine | agonist | Ki(nM) = 117.0 | VMWNQDUVQKEIOC-CYBMUJFWSA-N | [H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23 |
25 | P08908_DB00726 | DB00726 | Trimipramine | antagonist | ZSCDBOWYZJWBIY-UHFFFAOYSA-N | CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12 | |
26 | P08908_DB00734 | DB00734 | Risperidone | antagonist | Ki(nM) = 21.0 EC50(nM) = 10000.0 | RAPZEAPATHNIPO-UHFFFAOYSA-N | CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1 |
27 | P08908_DB00866 | DB00866 | Alprenolol | antagonist | PAZJSJFMUHDSTF-UHFFFAOYSA-N | CC(C)NCC(O)COC1=CC=CC=C1CC=C | |
28 | P08908_DB00904 | DB00904 | Ondansetron | other/unknown | Ki(nM) = 10000.0 | FELGMEQIXOGIFQ-UHFFFAOYSA-N | CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2 |
29 | P08908_DB00935 | DB00935 | Oxymetazoline | agonist | EC50(nM) = 70.0 | WYWIFABBXFUGLM-UHFFFAOYSA-N | CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C |
30 | P08908_DB00952 | DB00952 | Naratriptan | agonist | Ki(nM) = 45.0 | AMKVXSZCKVJAGH-UHFFFAOYSA-N | CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1 |
31 | P08908_DB00960 | DB00960 | Pindolol | antagonist | Ki(nM) = 15.0 EC50(nM) = 27.0 | JZQKKSLKJUAGIC-UHFFFAOYSA-N | CC(C)NCC(O)COC1=CC=CC2=C1C=CN2 |
32 | P08908_DB00988 | DB00988 | Dopamine | binder | Ki(nM) = 8248.0 | VYFYYTLLBUKUHU-UHFFFAOYSA-N | NCCC1=CC(O)=C(O)C=C1 |
33 | P08908_DB01142 | DB01142 | Doxepin | antagonist | ODQWQRRAPPTVAG-UHFFFAOYSA-N | [H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12 | |
34 | P08908_DB01149 | DB01149 | Nefazodone | antagonist | Ki(nM) = 80.0 | VRBKIVRKKCLPHA-UHFFFAOYSA-N | CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1 |
35 | P08908_DB01151 | DB01151 | Desipramine | binder | Ki(nM) = 6400.0 | HCYAFALTSJYZDH-UHFFFAOYSA-N | CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
36 | P08908_DB01175 | DB01175 | Escitalopram | inhibitor | WSEQXVZVJXJVFP-FQEVSTJZSA-N | CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1 | |
37 | P08908_DB01186 | DB01186 | Pergolide | agonist | Ki(nM) = 1.8 | YEHCICAEULNIGD-MZMPZRCHSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC |
38 | P08908_DB01200 | DB01200 | Bromocriptine | agonist | Ki(nM) = 12.88 | OZVBMTJYIDMWIL-AYFBDAFISA-N | [H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C |
39 | P08908_DB01224 | DB01224 | Quetiapine | antagonist | Ki(nM) = 79.0 | URKOMYMAXPYINW-UHFFFAOYSA-N | OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12 |
40 | P08908_DB01238 | DB01238 | Aripiprazole | partial agonist | Ki(nM) = 1.7 EC50(nM) = 24.0 | CEUORZQYGODEFX-UHFFFAOYSA-N | ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl |
41 | P08908_DB01267 | DB01267 | Paliperidone | antagonist | Ki(nM) = 480.0 EC50(nM) = 10000.0 | PMXMIIMHBWHSKN-UHFFFAOYSA-N | CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1 |
42 | P08908_DB01359 | DB01359 | Penbutolol | antagonist | KQXKVJAGOJTNJS-HNNXBMFYSA-N | CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1 | |
43 | P08908_DB01392 | DB01392 | Yohimbine | partial agonist | Ki(nM) = 50.11 | BLGXFZZNTVWLAY-SCYLSFHTSA-N | [H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2 |
44 | P08908_DB01614 | DB01614 | Acepromazine | antagonist | NOSIYYJFMPDDSA-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O | |
45 | P08908_DB01616 | DB01616 | Alverine | antagonist | ZPFXAOWNKLFJDN-UHFFFAOYSA-N | CCN(CCCC1=CC=CC=C1)CCCC1=CC=CC=C1 | |
46 | P08908_DB01618 | DB01618 | Molindone | antagonist | Ki(nM) = 1204.81 | KLPWJLBORRMFGK-UHFFFAOYSA-N | CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2 |
47 | P08908_DB01621 | DB01621 | Pipotiazine | antagonist | JOMHSQGEWSNUKU-UHFFFAOYSA-N | CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1 | |
48 | P08908_DB04829 | DB04829 | Lysergic acid diethylamide | n/a | Ki(nM) = 1.09 | VAYOSLLFUXYJDT-RDTXWAMCSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC |
49 | P08908_DB04884 | DB04884 | Dapoxetine | n/a | USRHYDPUVLEVMC-FQEVSTJZSA-N | CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C12)C1=CC=CC=C1 | |
50 | P08908_DB04888 | DB04888 | Bifeprunox | n/a | Ki(nM) = 7.19 EC50(nM) = 324.0 | CYGODHVAJQTCBG-UHFFFAOYSA-N | O=C1NC2=C(O1)C(=CC=C2)N1CCN(CC2=CC(=CC=C2)C2=CC=CC=C2)CC1 |
51 | P08908_DB04908 | DB04908 | Flibanserin | agonist | PPRRDFIXUUSXRA-UHFFFAOYSA-N | FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1 | |
52 | P08908_DB04946 | DB04946 | Iloperidone | antagonist | Ki(nM) = 33.0 | XMXHEBAFVSFQEX-UHFFFAOYSA-N | COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O |
53 | P08908_DB04948 | DB04948 | Lofexidine | agonist | Ki(nM) = 126.0 | KSMAGQUYOIHWFS-UHFFFAOYSA-N | CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1 |
54 | P08908_DB04970 | DB04970 | Lesopitron | n/a | Ki(nM) = 50.0 | AHCPKWJUALHOPH-UHFFFAOYSA-N | ClC1=CN(CCCCN2CCN(CC2)C2=NC=CC=N2)N=C1 |
55 | P08908_DB05271 | DB05271 | Rotigotine | agonist | KFQYTPMOWPVWEJ-INIZCTEOSA-N | CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1 | |
56 | P08908_DB05339 | DB05339 | MN-305 | n/a | GGNCUSDIUUCNKE-RSAXXLAASA-N | Cl.C(CNC[C@H]1COC2=CC=CC=C2O1)COC1=CC2=C(OCO2)C=C1 | |
57 | P08908_DB05562 | DB05562 | Naluzotan | agonist | SPWZXWDPAWDKQE-UHFFFAOYSA-N | CC(=O)NC1=CC=CC(=C1)N1CCN(CCCCNS(=O)(=O)CC2CCCCC2)CC1 | |
58 | P08908_DB06016 | DB06016 | Cariprazine | partial agonist | Ki(nM) = 2.6 | KPWSJANDNDDRMB-QAQDUYKDSA-N | CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1 |
59 | P08908_DB06148 | DB06148 | Mianserin | blocker | UEQUQVLFIPOEMF-UHFFFAOYSA-N | CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21 | |
60 | P08908_DB06153 | DB06153 | Pizotifen | partial agonist | FIADGNVRKBPQEU-UHFFFAOYSA-N | CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2 | |
61 | P08908_DB06216 | DB06216 | Asenapine | antagonist | Ki(nM) = 10.0 | VSWBSWWIRNCQIJ-UHFFFAOYSA-N | CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1 |
62 | P08908_DB06393 | DB06393 | Xaliproden | n/a | WJJYZXPHLSLMGE-UHFFFAOYSA-N | FC(F)(F)C1=CC(=CC=C1)C1=CCN(CCC2=CC3=CC=CC=C3C=C2)CC1 | |
63 | P08908_DB06446 | DB06446 | Dotarizine | n/a | LRMJAFKKJLRDLE-UHFFFAOYSA-N | C(CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)CC1(OCCO1)C1=CC=CC=C1 | |
64 | P08908_DB06454 | DB06454 | Sarizotan | n/a | HKFMQJUJWSFOLY-OAQYLSRUSA-N | FC1=CC=C(C=C1)C1=CN=CC(CNC[C@H]2CCC3=CC=CC=C3O2)=C1 | |
65 | P08908_DB06506 | DB06506 | Repinotan | n/a | YGYBFMRFXNDIPO-QGZVFWFLSA-N | O=C1N(CCCCNC[C@H]2CCC3=CC=CC=C3O2)S(=O)(=O)C2=CC=CC=C12 | |
66 | P08908_DB06538 | DB06538 | Robalzotan | n/a | MQTUXRKNJYPMCG-CYBMUJFWSA-N | NC(=O)C1=C2C[C@H](COC2=C(F)C=C1)N(C1CCC1)C1CCC1 | |
67 | P08908_DB06684 | DB06684 | Vilazodone | agonist | Ki(nM) = 0.2 IC50(nM) = 0.11 EC50(nM) = 0.12 | SGEGOXDYSFKCPT-UHFFFAOYSA-N | NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1 |
68 | P08908_DB08807 | DB08807 | Bopindolol | n/a | UUOJIACWOAYWEZ-UHFFFAOYSA-N | CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1 | |
69 | P08908_DB08810 | DB08810 | Cinitapride | agonist | ZDLBNXXKDMLZMF-UHFFFAOYSA-N | CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O | |
70 | P08908_DB08815 | DB08815 | Lurasidone | antagonist | Ki(nM) = 6.7 | PQXKDMSYBGKCJA-CVTJIBDQSA-N | [H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O |
71 | P08908_DB08922 | DB08922 | Perospirone | partial agonist | FBVFZWUMDDXLLG-HDICACEKSA-N | [H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O | |
72 | P08908_DB09061 | DB09061 | Cannabidiol | agonist | QHMBSVQNZZTUGM-ZWKOTPCHSA-N | CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1 | |
73 | P08908_DB09068 | DB09068 | Vortioxetine | agonist | YQNWZWMKLDQSAC-UHFFFAOYSA-N | CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1 | |
74 | P08908_DB09128 | DB09128 | Brexpiprazole | agonist | Ki(nM) = 0.12 | ZKIAIYBUSXZPLP-UHFFFAOYSA-N | O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1 |
75 | P08908_DB09167 | DB09167 | Dosulepin | antagonist | PHTUQLWOUWZIMZ-GZTJUZNOSA-N | CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12 | |
76 | P08908_DB09244 | DB09244 | Pirlindole | antagonist | IWVRVEIKCBFZNF-UHFFFAOYSA-N | CC1=CC=C2N3CCNC4CCCC(=C34)C2=C1 | |
77 | P08908_DB09289 | DB09289 | Tianeptine | inhibitor | JICJBGPOMZQUBB-UHFFFAOYSA-N | CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O | |
78 | P08908_DB11755 | DB11755 | Tetrahydrocannabivarin | agonist | ZROLHBHDLIHEMS-HUUCEWRRSA-N | CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1 | |
79 | P08908_DB12061 | DB12061 | Pardoprunox | n/a | YVPUUUDAZYFFQT-UHFFFAOYSA-N | CN1CCN(CC1)C1=C2OC(=O)NC2=CC=C1 | |
80 | P08908_DB12540 | DB12540 | Lecozotan | antagonist | NRPQELCNMADTOZ-OAQYLSRUSA-N | C[C@H](CN(C(=O)C1=CC=C(C=C1)C#N)C1=CC=CC=N1)N1CCN(CC1)C1=CC=CC2=C1OCCO2 | |
81 | P08908_DB14010 | DB14010 | 5-methoxy-N,N-dimethyltryptamine | agonist | ZSTKHSQDNIGFLM-UHFFFAOYSA-N | COC1=CC=C2NC=C(CCN(C)C)C2=C1 | |
82 | P08908_DB14011 | DB14011 | Nabiximols | n/a | SSNHGLKFJISNTR-DYSNNVSPSA-N | [H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C | |
83 | P08908_DB14185 | DB14185 | Aripiprazole lauroxil | partial agonist | DDINXHAORAAYAD-UHFFFAOYSA-N | CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12 | |
84 | P08908_DB15665 | DB15665 | SEP-363856 | agonist | ABDDQTDRAHXHOC-QMMMGPOBSA-N | CNC[C@@H]1OCCC2=C1SC=C2 | |
85 | P08908_DB16629 | DB16629 | Serdexmethylphenidate | agonist | UBZPNQRBUOBBLN-PWRODBHTSA-N | [H][C@@]1(CCCCN1C(=O)OC[N+]1=CC=CC(=C1)C(=O)N[C@@H](CO)C([O-])=O)[C@H](C(=O)OC)C1=CC=CC=C1 |